Malignant tumors of the anterolateral skull base

Keyphrases

• Malignant Tumor 100%
• Anterolateral Skull Base 100%
• Median Progression-free Survival 75%
• Tumor 50%
• Sarcoma 50%
• Combined Modality Therapy 50%
• Progression-free Survival 50%
• 5-year Survival 50%
• 2-year Survival 50%
• Squamous Cell Carcinoma (SqCC) 50%
• Skull Base Malignancy 50%
• Survival Median 50%
• Low-grade Sarcoma 50%
• Anterior Skull Base 50%
• Cranial Nerve Palsy 50%
• High-grade Sarcoma 50%
• Adenoid Cystic Carcinoma (AdCC) 50%
• Malignancy 25%
• Median Survival 25%
• Distant Metastasis 25%
• Facial numbness 25%
• In(III) 25%
• Pneumonia 25%
• Surgery Therapy 25%
• Skull Base 25%
• Treatment Complications 25%
• Common Complications 25%
• Treatment Protocol 25%
• Living Patients 25%
• Neuropathy 25%
• Cranial Nerve Deficit 25%
• Exclusion Criteria 25%
• Skull Base Surgery 25%
• Flap Necrosis 25%
• Temporal Bone 25%
• Trigeminal Neuropathy 25%
• Temporal Bone Malignancy 25%
• Abducens 25%
• 95% Confidence Interval 25%
• Multiple Complications 25%
• Skull Base Lesions 25%
• Index Surgery 25%

Medicine and Dentistry

• Cancer 100%
• Skull Base 100%
• Connective Tissue Cancer 85%
• Progression Free Survival 57%
• Squamous Cell Carcinoma 28%
• Recurrent Disease 28%
• Cylindroma 28%
• Tumor 28%
• Cranial Nerve Paralysis 28%
• Temporal Bone 28%
• Survival Time 14%
• Paresthesia 14%
• Neuropathy 14%
• Trigeminal Neuralgia 14%
• Cranial Nerve 14%
• Skull Surgery 14%
• Graft Necrosis 14%
• Complication of Treatment 14%
• Pneumonia 14%